Literature DB >> 18641337

Tetrameric and homodimeric camelid IgGs originate from the same IgH locus.

Ikbel Achour1, Patricia Cavelier, Magali Tichit, Christiane Bouchier, Pierre Lafaye, François Rougeon.   

Abstract

In addition to producing conventional tetrameric IgGs, camelids have the particularity of producing a functional homodimeric IgG type lacking L (light) chains and only made up of two H (heavy) chains. This nonconventional IgG type is characterized by variable and constant regions referred to as V(H)H and C(H)H, respectively, and which differ from conventional V(H) and C(H) counterparts. Although the structural properties of homodimeric IgGs have been well investigated, the genetic bases involved in their generation are still largely unknown. In this study, we characterized the organization of genes coding for the H chains of tetrameric and homodimeric IgGs by constructing an alpaca (Lama pacos) genomic cosmid library. We showed that a single IgH locus in alpaca chromosome 4 contains all of the genetic elements required for the generation of the two types of Igs. The alpaca IgH locus is composed of a V region that contains both V(H)H and V(H) genes followed by a unique D(H)-J(H) cluster and C region genes, which include both C(H)H and C(H) genes. Although this general gene organization greatly resembles that of other typical mammalian V(n)-D(n)-J(n)-C(n) translocon IgH loci, the intermixed gene organization within the alpaca V and C regions reveals a new type of translocon IgH locus. Furthermore, analyses of cDNA coding for the membrane forms of IgG and IgM present in alpaca peripheral blood B cells are most consistent with the notion that the development of a B cell bearing homodimeric IgG passes through an IgM(+) stage, similar to the case for conventional IgG.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641337     DOI: 10.4049/jimmunol.181.3.2001

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Contributions of conventional and heavy-chain IgG to immunity in fetal, neonatal, and adult alpacas.

Authors:  L P Daley-Bauer; S R Purdy; M C Smith; L F Gagliardo; W C Davis; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

Review 2.  Structural and genetic diversity in antibody repertoires from diverse species.

Authors:  Miguel de los Rios; Michael F Criscitiello; Vaughn V Smider
Journal:  Curr Opin Struct Biol       Date:  2015-07-17       Impact factor: 6.809

Review 3.  Distinct antibody species: structural differences creating therapeutic opportunities.

Authors:  Serge Muyldermans; Vaughn V Smider
Journal:  Curr Opin Immunol       Date:  2016-02-27       Impact factor: 7.486

4.  Intracellular Neutralization of Ricin Toxin by Single-domain Antibodies Targeting the Active Site.

Authors:  Michael J Rudolph; Timothy F Czajka; Simon A Davis; Chi My Thi Nguyen; Xiao-Ping Li; Nilgun E Tumer; David J Vance; Nicholas J Mantis
Journal:  J Mol Biol       Date:  2020-01-10       Impact factor: 5.469

5.  Llama peripheral B-cell populations producing conventional and heavy chain-only IgG subtypes are phenotypically indistinguishable but immunogenetically distinct.

Authors:  Kevin A Henry; Henk van Faassen; Doreen Harcus; Anne Marcil; Jennifer J Hill; Serge Muyldermans; C Roger MacKenzie
Journal:  Immunogenetics       Date:  2019-01-18       Impact factor: 2.846

6.  Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's disease.

Authors:  Matthias Vandesquille; Tengfei Li; Chrystelle Po; Christelle Ganneau; Pascal Lenormand; Clémence Dudeffant; Christian Czech; Fiona Grueninger; Charles Duyckaerts; Benoît Delatour; Marc Dhenain; Pierre Lafaye; Sylvie Bay
Journal:  MAbs       Date:  2017-06-28       Impact factor: 5.857

7.  Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform.

Authors:  Alex Klarenbeek; Khalil El Mazouari; Aline Desmyter; Christophe Blanchetot; Anna Hultberg; Natalie de Jonge; Rob C Roovers; Christian Cambillau; Sylvia Spinelli; Jurgen Del-Favero; Theo Verrips; Hans J de Haard; Ikbel Achour
Journal:  MAbs       Date:  2015       Impact factor: 5.857

8.  Landscape of variable domain of heavy-chain-only antibody repertoire from alpaca.

Authors:  Zhui Tu; Xiaoqiang Huang; Jinheng Fu; Na Hu; Wei Zheng; Yanping Li; Yang Zhang
Journal:  Immunology       Date:  2020-06-30       Impact factor: 7.397

Review 9.  Genome edited B cells: a new frontier in immune cell therapies.

Authors:  Geoffrey L Rogers; Paula M Cannon
Journal:  Mol Ther       Date:  2021-09-24       Impact factor: 11.454

10.  Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.

Authors:  Jianliang Xu; Kai Xu; Peter D Kwong; Rafael Casellas; Seolkyoung Jung; Andrea Conte; Jenna Lieberman; Frauke Muecksch; Julio Cesar Cetrulo Lorenzi; Solji Park; Fabian Schmidt; Zijun Wang; Yaoxing Huang; Yang Luo; Manoj S Nair; Pengfei Wang; Jonathan E Schulz; Lino Tessarollo; Tatsiana Bylund; Gwo-Yu Chuang; Adam S Olia; Tyler Stephens; I-Ting Teng; Yaroslav Tsybovsky; Tongqing Zhou; Vincent Munster; David D Ho; Theodora Hatziioannou; Paul D Bieniasz; Michel C Nussenzweig
Journal:  Nature       Date:  2021-06-07       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.